FHIT and lung carcinoma: To investigate the synthetic lethal targets of FHIT in lung cancer, we established FHIT-isogenic lung cancer cell pairs via CRISPR/Cas9 gene knockout (KO) and lentiviral FHIT overexpression (OE).